The latest headlines across every section, pulled from official and open-access sources.
This systematic review and meta-analysis of studies of US veterans receiving cancer care through the Veterans Health Administration compares outcomes for Black veterans compared with veterans from other racial groups.
This case-control study investigates compares limbic system microstructure in neonates with vs without opioid exposure.
This systematic review and meta-analysis examines factors associated with risk of suicide mortality in individuals aged 24 years and younger.
This cross-sectional study provides US national estimates and investigates the characteristics of older adults who receive care from friends vs family caregivers.
This cohort study investigates associations between the 2024 to 2025 trainee physician walkout and mortality, health care usage, and spending patterns in South Korea.
This case-control study uses Danish registry data to examine whether different progestogens used as hormonal contraception are associated with risk of meningiomas.
The HHS Secretary determined that circumstances no longer exist justifying the authorization of emergency use of drugs and biological products during the COVID-19 pandemic. The authorizing emergency use of drug and biological products for COVID-19 will be terminated.
Evernorth is investing $100 million through 2028 in Pharmacy Forward, an AI-powered program aimed at improving specialty pharmacy operations and patient care. The post Evernorth Invests $100M for AI Specialty Pharmacy Program appeared first on MedCity News .
The U.S. Food and Drug Administration today issued a supplemental approval for Casgevy (exagamglogene autotemcel) for patients aged 2 years and older with either sickle cell disease (SCD) with recurrent vaso-occlusive crises (VOCs) or transfusion-dependent β thalassemia (TDT).
CINCINNATI--(BUSINESS WIRE)--Kao USA Inc. (“Kao USA”) today issued a voluntary recall of select lots of its Oribe Serene Scalp Densifying Shampoo (8.5 oz and 33.8 oz) in the U.S. and Canada due to the detection of Pluralibacter gergoviae bacteria.
The Food and Drug Administration continues advising consumers not to purchase or use MAGNUM brand products sold for sexual enhancement across various websites and retail stores. FDA laboratory analysis has confirmed that MAGNUM brand products sold in various dosage forms including capsules and honey
July 01, 2026 EUNHA FISHERIES CO., LTD., Busan, Republic of Korea, is recalling certain Sliced Korean Halibut and Flounder Sashimi products because the accompanying soy sauce and vinegar red pepper paste packets contain wheat, soy, and sesame that were not declared in English on the individual condi
Same-day coadministration of COVID-19 and influenza vaccines was not associated with an increased risk for adverse events in 3 updated-formulation periods. These findings support the short-term safety of coadministration.
To protect public health and safety, the FDA provides guidance to drug manufacturers on staying cyber secure.
CDC: Early West Nile season brings record cases; protect against mosquito bites this holiday weekend
Current guidelines for management of atrial fibrillation (AF) recommend continuation of oral anticoagulation (OAC) following successful catheter ablation of AF for patients deemed at elevated thromboembolic risk.
FDA has proposed the development of a rating system that will help incentivize drug manufacturers to achieve Quality Mangement Maturity at their facilities.
While the company no longer manufactures the radiographic markers, healthcare providers are still advised to monitor patients who have had them implanted.
Original premarket approvals are taking “substantially longer” than last year, according to a report from BTIG.
New policy paper outlines recommendations to strengthen oversight and transparency of private equity and corporatization in healthcare and their effects on clinical autonomy and care delivery.
In this episode, we’re joined by Dr. Cathleen Brown, medical director of menopause company Winona. We discuss the company’s new Winona Research Initiative, which seeks to fund and support menopause and women’s health research. The post MedCity FemFwd: Inside Winona’s New Women’s Health Research Initiative appeared first on MedCity News .
A novel sarcopenic obesity index served as a clinically meaningful predictor of cardiovascular risk and lent further insight into accompanying genetics and possible therapeutic targets, according to research published July 1 in JACC.
Merck & Co. has nixed the phase 2 study of a potential Alzheimer’s disease medicine after the drug underwhelmed in an interim analysis, marking another blow for the pharma’s struggling partner Neuphoria Therapeutics.
Insilico Medicine has signed a deal worth up to $600 million with Japanese Big Pharma Takeda to collaborate on discovery of assets across Takeda’s therapeutic areas of interest.